Through the creation, registration, and administration of vital proprietary assets, such as manufacturing, know-how, products, methods, and expertise, Sano Stemedica has maintained a competitive edge. The goal of Sano Stemedica’s internal patent department is to identify and safeguard the Company’s intellectual property.
The patent department implements a thorough program to stop rivals from copying, avoiding, or reverse-engineering its most valuable assets. Trade secrets and patents are two facets of the Company’s intellectual property program. Seven approved “keystone patents” and fourteen published and pending applications in the USPTO make up the published component of Sano Stemedica’s intellectual property portfolio.
Issued Patents:
- US 8,105,380 – Cellular Scaffold (Issued: January 31, 2012)
- US 8,709,081 – Cellular Scaffold (Issued: April 29, 2014)
- US 8,420,394 – Culturing Ectodermal Cells Under Reduced Oxygen Tension (Issued: April 16, 2013)
- Includes a continuation application for treating CNS disorders
- US 8,642,286 – Methods for Identifying Neuripotent Cells (Issued: February 4, 2014)
- US 8,318,485 – Stem Cell Therapy for Diabetic Retinopathy and Optic Neuropathy (Issued: November 27, 2012)
- US 8,790,638 – Compositions of Stem Cells and Stem Cell Factors, Methods for Use and Manufacture (Issued: July 29, 2014)
- US 9,080,184 – Transgenic Therapeutic Stem Cells, Methods for Use and Manufacture (Issued: July 14, 2015)
Published U.S. Patent Applications:
- US 2016/0287668 – Sandwiched Biodegradable Microneedle
- US 2017/0252373 – Combination Therapy for Hair Loss Treatment
- US 2012/0141433 – Vaporized Stem Cell Derivatives for Therapeutic Uses
- US 2012/0201786 – Methods for Using Stem Cells in Treating Skin Conditions
- US 2016/0324898 – Compositions & Methods for Alzheimer’s Disease Treatment
- US 2016/0222349 – Differentiation of RPE Progenitors into Neuron-Like Cells
- US 2017/0027990 – Treatment of Mental State After Ischemic Brain Injury with Ischemic-Tolerant Allogeneic Mesenchymal Bone Marrow Cells
- US 2016/0143950 – Stem Cells for Inhibiting Alzheimer’s Disease Progression
- US 2014/0286910 – Enhancing Stem Cell Proliferation & Plasticity via Environmental Factors
- US 2013/0177537 – Stem Cell Therapy for Central Nervous System Disorders
- US 2016/0220611 – Ischemic Tolerant Cells for Treating Acute Coronary Syndrome
- US 2008/0292598 – Chimeric Transplant
- US 2007/0231307 – Energy-Assisted Stem Cell Extract
- US 2013/0085468 – Catheter with Body Wall Separator
